Filing Details
- Accession Number:
- 0001683168-18-001945
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-12 17:20:12
- Reporting Period:
- 2018-07-10
- Accepted Time:
- 2018-07-12 17:20:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1355790 | International Stem Cell Corp | ISCO.OB | Pharmaceutical Preparations (2834) | 204494098 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1616590 | Sophia Garnette | C/O International Stem Cell Corporation 5950 Priestly Drive Carlsbad CA 92008 | Vp, Legal Affairs & Operation | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-10 | 2,833 | $1.09 | 3,100 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-07-10 | 2,833 | $1.58 | 267 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-07-10 | 2,833 | $0.00 | 18,600 | $1.09 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,767 | 2027-02-10 | No | 4 | M | Direct |
Footnotes
- The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share.
- The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months.